Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 50 (KRT8P50) is a human type II keratin pseudogene. It is one of eight known type II keratin pseudogenes which lack protein-coding capacity and do not give rise to functional proteins[5]. As such, KRT8P50 does not play a direct biological role and is not a drug target, biomarker, or therapeutic candidate. Its presence is relevant only for gene annotation and nomenclature purposes. The closely related keratin 8 gene (KRT8), by contrast, encodes a type II cytoskeletal protein expressed in simple epithelia and is biologically and clinically significant[1][5][7]. However, KRT8P50 itself is not a functional gene. Key context: According to the revised mammalian keratin gene nomenclature, human keratin pseudogenes (both type I and II) are formally recognized but are numbered following the functional gene sets. There are currently 8 type II keratin pseudogenes of which KRT8P50 may be one, though full public entries specifically for KRT8P50 are sparse—it is not a major entity in clinical, pharmacological, or functional molecular databases[5]. Pseudogenes are generally transcribed non-coding gene fragments or relics of gene duplication events, and rarely (if ever) encode functional proteins in humans[5]. Keratin pseudogenes like KRT8P50 are important for gene annotation studies but do not function as molecular targets or disease-associated receptors/enzymes. If you meant the functional keratin 8 gene (KRT8), see [1][2][7] for details on its genuine biological roles and disease links. Summary: Keratin 8 pseudogene 50 (KRT8P50) is not a protein, target, or biological effector; it is a type II keratin pseudogene, included for completeness in keratin gene family references and does not have therapeutic or diagnostic value[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 50 (KRT8P50).